Thoracic Tumor Board

MGR27032

In the United States, lung cancer continues to be the leading cause of cancer-related fatalities, accounting for approximately 20% of all cancer deaths. It is alarming that approximately 229,410 Americans are projected to receive a lung cancer diagnosis in 2026 alone, resulting in the loss of 124,990 lives. (Source: Cancer Facts & Figures, American Cancer Society 2026)

At UCSF Helen Diller Family Comprehensive Cancer Center, our Chief, Thoracic Surgery, Dr. Johannes Kratz, leads the Thoracic Surgery & Oncology Tumor Board. This program is accredited by the ACCME and aims to educate practicing physicians and nurses specializing in thoracic oncology, pulmonology, radiation oncology, pathology, and surgery. Its objective is to promote evidence-based best practices for managing patients with lung malignancies. By following these guidelines, we aim to extend disease-free progression, enhance overall survival, and improve quality of life for our patients.

This program is specifically designed for practicing physicians and nurses at UCSF who specialize in thoracic oncology, pulmonology, radiation oncology, pathology, and surgery.

In support of improving patient care, the University of California, San Francisco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

UCSF designates this activity for a maximum of 50 AMA PRA Category 1 Credit(s)TM*.

Physicians should claim credit commensurate with their participation in the activity during AY 26-27

Tutorial Videos for Learners
How to Access the CE Portal?
How to Create a New Account?
How to Login into the CE portal?
How a Learner can view and claim the CE credit?